Clinical Trial Update: Pazopanib and Vinflunine in Urothelial Cancer of the Bladder [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update of pazopanib and vinflunine in advanced urothelial carcinoma of the bladder after platinum therapy failure; the study status is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Carcinoma of the Bladder

Drugs mentioned

• Javlor (vinflunine)
• Votrient (Pazopanib)

Snippet

Sponsor: Prof. Dr. Thomas Otto | Conditions: Advanced Urothelial Cancer of Bladder After Failure of Platinum-containing Therapy. | Phase 1, Phase 2 | Status: COMPLETED